Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Jan Borén(Göteborgs Stads), Henry N. Ginsberg(Columbia University), Kausik K. Ray(Imperial College London), Heribert Schunkert(German Centre for Cardiovascular Research), Olov Wiklund(Translational Therapeutics (United States)), Lâle Tokgözoğlu(Hacettepe University), Jay D. Horton(Center for Human Genetics), Bart van de Sluis(University of Groningen), Robert A. Hegele(Western University), Gerard Pasterkamp(University Medical Center Utrecht), Frederick J. Raal(University of the Witwatersrand), Mat J.A.P. Daemen(Amsterdam Neuroscience), Ian Graham(Ottawa Hospital), Éric Bruckert(Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société), Stephen J. Nicholls(Australian Centre for Heart Health), L. Masana(Universitat Rovira i Virgili), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Ulrich Laufs(University Hospital Leipzig), M. John Chapman(University of Cambridge), Linda L. Demer(University of California, Los Angeles), Christoph J. Binder(Medical University of Vienna), Ronald M. Krauss(University of California System), Gerald F. Watts(Royal Perth Hospital), Børge G. Nordestgaard(Gentofte Hospital), Ulf Landmesser(Deutsches Herzzentrum der Charité), Alberico L. Catapano(University of Milan), Sergio Fazio(Regeneron (United States)), Jacob Fog Bentzon(Steno Diabetes Centers), Brian A. Ference, Chris J. Packard(University of Glasgow)
European Heart Journal
January 8, 2020
Cited by 1,520


Related Papers